Qube Research & Technologies LTD Emergent Bio Solutions Inc. Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 274,154 shares of EBS stock, worth $1.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

274,154

Holding current value

$1.92 Million

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.86 - $6.98 $509,926 - $1.91 Million	274,154 New	274,154 $1.87 Million
Q4 2023 Feb 13, 2024	BUY	$1.82 - $3.16 $1.13 Million - $1.96 Million	621,177 New	621,177 $1.49 Million
Q2 2023 Aug 14, 2023	BUY	$7.35 - $13.21 $265,761 - $477,647	36,158 New	36,158 $265,000
Q4 2022 Feb 14, 2023	BUY	$11.0 - $21.45 $1 Million - $1.96 Million	91,261 Added 204.49%	135,889 $1.6 Million
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $443,768 - $790,786	22,089 Added 98.0%	44,628 $937,000
Q2 2022 Aug 15, 2022	BUY	$27.42 - $43.63 $12,997 - $20,680	474 Added 2.15%	22,539 $700,000
Q1 2022 May 09, 2022	BUY	$36.48 - $52.22 $804,931 - $1.15 Million	22,065 New	22,065 $906,000
Q4 2021 Feb 01, 2022	SELL	$33.11 - $55.01 $475,294 - $789,668	-14,355 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$50.07 - $66.05 $234,778 - $309,708	4,689 Added 48.51%	14,355 $719,000
Q2 2021 Aug 13, 2021	BUY	$56.61 - $80.46 $547,192 - $777,726	9,666 New	9,666 $609,000
Q4 2020 Feb 16, 2021	SELL	$79.17 - $111.47 $1.47 Million - $2.07 Million	-18,530 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$81.91 - $134.94 $1.52 Million - $2.5 Million	18,530 New	18,530 $1.92 Million

Others Institutions Holding EBS

# of Institutions

154

Shares Held

30.2M

Call Options Held

137K

Put Options Held

706K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $349M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Emergent Bio Solutions Inc. Transaction History